Biotech

All Articles

Novartis fires up brand new phase of Voyager contract with $15M capsid bargain

.Novartis is opening a brand new frontier in its cooperation along with Voyager Therapeutics, spendi...

Lilly posts even more positive records on its weekly the hormone insulin possibility

.On the heels of an FDA turndown for its own primary competing Novo Nordisk, Eli Lilly is actually p...

IN 8bio standstills phase 2 trial, lays off one-half of labor force

.Merely a couple of months after application the first person in a stage 2 trial for newly identifie...

Lilly, Haya ink $1B biobuck excessive weight deal to look black genome

.Eli Lilly's search for weight problems aim ats has actually led it to the darker genome. The Big Ph...

ArsenalBio raises $325M, rotates out of former lead property

.Toolbox Biosciences is actually moving on up. The tissue therapy business has added $325 million in...

Lilly- supported weight reduction biotech documents IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis use drug flunks phase 2b, driving Indivior to rethink $100M choice

.Aelis Farma's chances of securing a quick, beneficial decision on a $one hundred million choice set...

ProKidney standstills period 3 test certainly not needed to have for cell treatment confirmation

.ProKidney has actually stopped some of a pair of stage 3 tests for its cell treatment for renal ill...

Vaxcyte climbs on 'remarkable' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what analysts called "sensational" period 1/2 information for its own 31-valent pn...

Recursion's human brain disease trial presents little evidence of effectiveness

.Recursion has actually stumbled by means of a very early test of its own tech-enabled approach to m...